Efavirenz capsules are a non-nucleoside reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection. Document Date Friday, April 28, 2023 Efavirenz PI_dated April 2022.pdf
